Two Sigma Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Sell |
392,452
-110,700
| -22% | -$1.04M | 0.01% | 855 |
|
|
2025
Q1 | $6.18M | Sell |
503,152
-32,800
| -6% | -$403K | 0.01% | 696 |
|
|
2024
Q4 | $7.09M | Sell |
535,952
-133,400
| -20% | -$1.76M | 0.02% | 586 |
|
|
2024
Q3 | $12.9M | Buy |
669,352
+48,100
| +8% | +$926K | 0.03% | 420 |
|
|
2024
Q2 | $12.8M | Buy |
621,252
+165,400
| +36% | +$3.4M | 0.03% | 463 |
|
|
2024
Q1 | $10.8M | Buy |
455,852
+304,400
| +201% | +$7.24M | 0.03% | 513 |
|
|
2023
Q4 | $3.27M | Buy |
151,452
+84,400
| +126% | +$1.82M | 0.01% | 1026 |
|
|
2023
Q3 | $974K | Sell |
67,052
-70,100
| -51% | -$1.02M | ﹤0.01% | 1535 |
|
|
2023
Q2 | $2.87M | Sell |
137,152
-126,200
| -48% | -$2.64M | 0.01% | 1018 |
|
|
2023
Q1 | $5.56M | Sell |
263,352
-54,500
| -17% | -$1.15M | 0.01% | 764 |
|
|
2022
Q4 | $8.09M | Sell |
317,852
-53,900
| -14% | -$1.37M | 0.02% | 578 |
|
|
2022
Q3 | $8.93M | Buy |
371,752
+18,900
| +5% | +$454K | 0.03% | 526 |
|
|
2022
Q2 | $6.79M | Sell |
352,852
-15,500
| -4% | -$298K | 0.02% | 641 |
|
|
2022
Q1 | $6.4M | Buy |
368,352
+13,800
| +4% | +$240K | 0.02% | 696 |
|
|
2021
Q4 | $7.76M | Buy |
354,552
+12,700
| +4% | +$278K | 0.02% | 589 |
|
|
2021
Q3 | $6.53M | Sell |
341,852
-86,600
| -20% | -$1.65M | 0.02% | 669 |
|
|
2021
Q2 | $7.36M | Sell |
428,452
-153,300
| -26% | -$2.63M | 0.02% | 683 |
|
|
2021
Q1 | $13M | Sell |
581,752
-85,800
| -13% | -$1.92M | 0.04% | 478 |
|
|
2020
Q4 | $14.8M | Buy |
667,552
+408,500
| +158% | +$9.08M | 0.04% | 427 |
|
|
2020
Q3 | $3.82M | Buy |
259,052
+58,500
| +29% | +$864K | 0.01% | 864 |
|
|
2020
Q2 | $2.97M | Buy |
200,552
+149,000
| +289% | +$2.21M | 0.01% | 1011 |
|
|
2020
Q1 | $566K | Buy |
51,552
+17,100
| +50% | +$188K | ﹤0.01% | 1748 |
|
|
2019
Q4 | $302K | Buy |
+34,452
| New | +$302K | ﹤0.01% | 2061 |
|